Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 71205-708

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 71205-708). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tramadol-figure1 (Tramadol Figure1)

A line graph comparing Tramadol plasma concentration over time between Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Immediate-Release (IR) Tablets 50 mg every 6 hours. The x-axis represents time in hours (0 to 24), and the y-axis represents plasma concentration in ng/mL. The graph shows fluctuation patterns for both formulations over a 24-hour period.*

FDA Label Image

Tramadol-figure2 (Tramadol Figure2)

A graph showing M1 concentration (ng/mL) over 24 hours comparing Tramadol Hydrochloride Extended-Release Tablets 200 mg taken once daily and Tramadol IR Tablets 50 mg taken every 6 hours. The chart plots time on the x-axis and M1 concentration on the y-axis with data points represented by solid and open circles for each formulation respectively.*

FDA Label Image

Tramadol-figure3 (Tramadol Figure3)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' displaying the percent of patients achieving various response thresholds. The x-axis shows Response Threshold as percent improvement from baseline (0 to 100%). The y-axis shows Percent of Patients Achieving Response (0 to 60%). Multiple lines represent different tramadol doses (100 mg, 200 mg, 300 mg, 400 mg) and placebo, illustrating decreasing patient response rates with higher thresholds.*

FDA Label Image

Tramadol-figure4 (Tramadol Figure4)

A line graph titled "Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis" showing percent of patients achieving response on the vertical axis and response threshold (percent improvement from baseline) on the horizontal axis. Two lines compare Tramadol Hydrochloride Extended-Release Tablets and placebo across various response thresholds.*

FDA Label Image

71205-708-30 (Tramadol Label 200mg)

Label for Tramadol HCl 200 mg extended-release tablets by Proficient Rx LP. The label indicates a prescription drug classified as Schedule C-IV, with 30 tablets per package. The tablet is described as white, round, biconvex with beveled edges, coated, and contains 200 mg tramadol hydrochloride. Manufacturer is Sun Pharmaceutical Industries Ltd, India. Storage instructions and legal information are included.*

FDA Label Image

Tramadol-structure (Tramadol Structure)

Chemical structure diagram of tramadol hydrochloride showing the arrangement of atoms and bonds in the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.